Program Schedule
The following presentations will be available for on-demand viewing through the close of the virtual meeting platform on April 29.
Recordings will be made available at 9:00 a.m. Eastern time.
Acquired Bone Marrow Failure Syndromes
Speaker: Bhavisha Patel, MD, National Institute of Health
Acute Myeloid Leukemia
Speaker: Alice Mims, MD, The Ohio State University
Acute Lymphoblastic Leukemia
Speaker: Marlise Luskin, MD, MSCE, Dana-Farber Cancer Institute
Chronic Lymphocytic Leukemia
Speaker: Anthony Mato, MD, MSCE, Memorial Sloan Kettering Cancer Center
Disorders of Hemostasis
Speaker: Tyler Buckner, MD, University of Colorado, Denver
Hematopoietic Stem Cell Transplantation
Speaker: Bart Scott, MD, Fred Hutchinson Cancer Research Center
ITP/TTP, Immune Hemolysis, and aHUS
Speaker: Camila Masias, MD, MPH, Florida International University
Lymphoma
Speaker: Manali Kamdar, MD, University of Colorado
Myelodysplastic Syndromes
Speaker: Uma Borate, MBBS, The Ohio State University
Myeloma & Plasma Cell Dyscrasia
Speaker: Hira Mian, MD, McMaster University
Myeloproliferative Neoplasms Including Chronic Myeloid Leukemia
Speaker: Vikas Gupta, MD, Princess Margaret Cancer Centre
Red Cell Disorders: Hemolysis, Iron, & Infection
Speaker: Marc Zumberg, MD, University of Florida
Sickle Cell Disease: Sickling and Other Hemoglobinopathies
Speaker: Oyebimbe Adesina, MD, UC Davis
Transfusion Medicine and Apheresis
Speaker: Trisha Wong, MD, MS, The Ohio State University
Venous Thromboembolism/Anticoagulation and Its Reversal
Speaker: Neil Zakai, MD University of Vermont
All the community live Q/A sessions will feature specific topics as well as the speakers who appeared on the prerecorded sessions released earlier in the week.
10:00 a.m. – 11:00 a.m.
- Leukemia Community Live Q/A
- ALL
- AML
- MDS
- Acquired Bone Marrow Failure Syndromes
11:00 a.m. – 12:00 p.m.
- Lymphoma Community Live Q/A
- CLL
- Lymphoma
12:00 p.m. – 1:00 p.m. (Lunch Break)
1:00 p.m. – 2:00 p.m.
- Plasma Cell Dyscrasia and MPN Community Live Q/A
- Myeloma & Plasma Cell Dyscrasia
- Hematopoietic Stem Cell Transplantation
- MPN Including CML
2:00 p.m. – 3:00 p.m.
- Coagulation Disorders Community Live Q/A
- Disorders of Hemostasis
- Venous Thromboembolism/Anticoagulation and Its Reversal
- ITP/TTP, Immune Hemolysis, and aHUS
3:00 p.m. – 4:00 p.m.
- Transition Medicine and Red Blood Cell Disorders Community Live Q/A
The following presentations, relevant to the Mediterranean region, will be available for on-demand viewing through the close of the virtual meeting platform on April 29.
Recordings will be made available at 9:00 a.m. Eastern time.
COVID and Heme-Related Complications
Speaker: Radhika Gangaraju, MD, University of Alabama, Birmingham
Sponsoring Society: Turkish Society of Hematology
Treatment of Cancer-Associated Thromboembolism
Speaker: Casey O’Connell, MD, University of Southern California
Sponsoring Society : Société Marocaine d’Hématologie
This live Q/A session will open with an executive summary of the prerecorded presentations and the opportunity for attendees to pose questions and engage in scientific discussion with leading experts in real time.
Live Question & Answer Session for the Mediterranean
Session Moderators: Reyhan Kucukkaya, MD, and Nisrine Khoubila, MD
Session Speakers: Radhika Gangaraju, MD, and Casey O'Connell, MD
Latin American Region
The following presentations, relevant to the Latin American region, will be available for on-demand viewing through the close of the virtual meeting platform on April 29.
Recordings will be made available at 9:00 a.m. Eastern time.
Follicular Lymphoma: Is There an Optimal Way to Define Risk?
Speaker: Maria Alejandra Torres Viera, MD, Central University of Venezuela
Sponsoring Society: Sociedad de Hematologia del Uruguay
Integration of Molecular Profile in Classification and Risk Stratification in Myelodysplastic Syndromes
Speaker: Maria Teresa Voso, MD, Policlinico di Tor Vergata
Sponsoring Society: Associação Brasileira de Hematologia, Hemoterapia, e Terapia Celular
Emerging Treatment Options: What is on the Horizon?
Speaker: Guillermo Garcia-Manero, MD, University of Texas
Sponsoring Society: Associação Brasileira de Hematologia, Hemoterapia, e Terapia Celular
For over a decade, ASH has hosted a Breakfast Session in conjunction with the Highlights of ASH in Latin America, which provides a forum for discussion and collaboration on current and emerging issues and priorities in the region. This year’s Panel on Cooperative Clinical Research Initiatives in Latin America will be co-chaired by Drs. Rodrigo Calado and Sebastian Galeano, and will offer an opportunity to hear from and discuss updates with leaders in the field on exciting initiatives in Latin America.
Opening Remarks
Speakers: Rodrigo Calado, MD, PhD (Brazil) and Sebastian Galeano, MD (Uruguay)
History of the Breakfast Session
Speaker: Raul Gabus, MD (Uruguay)
VTE Guidelines
Speaker: Jaime Pereira, MD (Chile)
Latin American Registry on Aplastic Anemia (LARAA)
Speaker: Vera Milovic, MD (Argentina)
T-Cell Registry in South America
Speaker: Astrid Pavlovsky, MD (Argentina)
Grupo Latinoamericano de Mielodisplasia (GLAM)
Speaker: Silvia Magalhaes, MD, PhD (Brazil)
Live Panel Discussion
All Speakers
This live Q/A session will open with an executive summary of the prerecorded presentations and the opportunity for attendees to pose questions and engage in scientific discussion with leading experts in real time.
Live Question & Answer Session for Latin America
Session Moderators: Carolina Oliver, MD, Silvia Magalhães, MD, PhD, and Pablo Muxi, MD
Speakers: Maria Alejandra Torres Viera, MD, Maria Teresa Voso, MD, and Guillermo Garcia-Manero, MD
Asia-Pacific Region
The following presentations, relevant to the Asia-Pacific region, will be available for on-demand viewing through the close of the virtual meeting platform on April 29.
Recordings will be made available at 9:00 a.m. Eastern time.
Measurable/Minimal Residual Disease in Patients with Acute Myeloid Leukemia
Speaker: Cheng-Hong Tsai, MD, National Taiwan University Hospital
Sponsoring Society: The Hematology Society of Taiwan
Acquired Aplastic Anemia: Successful Management of Adult Patients in a Resource Limited Setting
Speaker: Visaka Ratnamalala, MD, National Hospital Sri Lanka
Sponsoring Society: Sri Lanka College of Hematologists
This live Q/A session will open with an executive summary of the prerecorded presentations and the opportunity for attendees to pose questions and engage in scientific discussion with leading experts in real time.
Live Question & Answer Session for Asia-Pacific
Session Moderators: Wen-Chien Chou, MD, PhD, and Cheng-Hong Tsai, MD
Speakers: Dammika Gunawardena, MD, and Visaka Ratnamalala, MD
Help ASH Build an Inclusive Hematology Community!
ASH is committed to building and nurturing a global hematology community and workforce inclusive of diverse perspectives, talents, and experiences as it works toward one collective goal: helping hematologists conquer blood diseases worldwide.
How Can You Help?
Visit your My Account page, make needed updates to your demographic details, and select your preferred level of ASH access to your information; aggregated or individually identifiable, or choose not to provide or share your information. By sharing information about who you are, you will help ASH have a better appreciation of the diverse needs and talents present in the field, and help to build a more inclusive, collaborative hematology community. It will take only a few moments to complete!
Update Access to Demographic Information Learn About Our Mission